Skip to Main Content

Paper Details

Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
Clin Genitourin Cancer
1
2023
Author NameAffiliation
Michael A CarducciDivision of Hematology /Oncology The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Timothy M KuzelDepartment of Medicine Northwestern University
  • 1 - 2

Datasets

Release 1.2